Bio-Techne is +37% over the past year while the S&P 500 is +18%: 19 points ahead of the market. 1-year return: +37% (S&P 500 +18%). vs 200-day average: +18%, a clear uptrend. RSI (14): 51, neutral. Below its 52-week high: 0.21%.

TECHBio-Techne

Healthcare

$72.47+37% 1Y

$72.47

$43.2252 weeks$72.62

What is the market doing?

Mixed

No clear lean: nothing decisive, though in an uptrend.

1 good, 1 neutral, 1 without data

TrendUptrendderived · Oct 9, 2026

In an uptrend, above its rising 50- and 200-day averages. Price is +18% vs its 200-day average.

Short interest0.0% of sharesFINRA · Sep 15, 2026

A token position, settled Sep 15, 2026, a few days of normal trading to cover. Up 13% since the previous count, unchanged over three months.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnbetter than 76% of the market

vs 200-day avgbetter than 83% of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How TECH is trading

Bio-Techne is +37% over the past year while the S&P 500 is +18%: 19 points ahead of the market.

+37%

1-year return · S&P 500 +18%

vs 200-day average: +18%
vs 200-day average · a clear uptrend
RSI (14): 51
RSI (14) · neutral
Below its 52-week high: 0.21%
Below its 52-week high

Sep 17, 2024$43.22 – $79.57 · dashed line: 200-day averageOct 9, 2026

Details›

Last close2026-10-09: $72.47
1 monthS&P 500 +2.7%: +0.50%
1 yearS&P 500 +18%: +37%
5 yearsS&P 500 +88%: −41%
vs 50-day average$72.32: +0.20%
52-week high: $72.62
52-week low: $43.22
Annualised volatility: 45%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08: −$320K

Calendar-year price return
Year	Return
2026 (year to date)	+24%
2025	−18%
2024	−6.2%
2023	−6.5%
2022	−36%
2021	+63%
2020	+45%
2019	+53%
2018	+13%
2017	+27%

Average return by calendar month, 2016–2026
Month	Years	Positive	Average
Jan	10	5 of 10	−0.31%
Feb	10	6 of 10	+0.24%
Mar	10	6 of 10	−0.46%
Apr	10	6 of 10	+1.6%
May	10	4 of 10	+2.9%
Jun	10	5 of 10	+2.4%
Jul	11	9 of 11	+6.8%
Aug	11	4 of 11	−1.8%
Sep	11	6 of 11	−1.2%
Oct	11	6 of 11	−0.80%
Nov	10	8 of 10	+5.2%
Dec	10	4 of 10	+0.52%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

On our screens:Stocks with no debt

Biotechnology

The closest names by size in the same industry

Kailera Therapeutics, Inc.

NVAX+16%

Novavax, Inc.

DNA+15%

Ginkgo Bioworks Holdings, Inc.